Advances in Pharmacological Sciences

Copyright © 2009 Sivakumar JT Gowder and Kenneth E. McMartin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. Y. M. Smulders and C. D. A. Stehouwer, “Folate metabolism and cardiovascular disease,” Seminars in Vascular Medicine, vol. 5, no. 2, pp. 87–97, 2005. View at Publisher · View at Google Scholar
2. D. M. Maddox, A. Manlapat, P. Roon, P. Prasad, V. Ganapathy, and S. B. Smith, “Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart,” BMC Developmental Biology, vol. 3, no. 6, pp. 1–8, 2003. View at Publisher · View at Google Scholar
3. C. M. Hatzis, G. K. Bertsias, M. Linardakis, J. M. Scott, and A. G. Kafatos, “Dietary and other lifestyle correlates of serum folate concentrations in a healthy adult population in Crete, Greece: a cross-sectional study,” Nutrition Journal, vol. 5, no. 5, pp. 1–10, 2006. View at Publisher · View at Google Scholar
4. D. Drogan, K. Klipstein-Grobusch, S. Wans, C. Luley, C. Boeing, and J. Dierkes, “Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study,” British Journal of Nutrition, vol. 92, no. 3, pp. 489–496, 2004. View at Publisher · View at Google Scholar
5. H. Birn, O. Spiegelstein, E. I. Christensen, and R. H. Finnell, “Renal tubular reabsorption of folate mediated by folate binding protein,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 608–615, 2005. View at Publisher · View at Google Scholar
6. K. M. Morshed and K. E. McMartin, “Reabsorptive and secretory 5-methyltetrahydrofolate transport pathways in cultured human proximal tubule cells,” American Journal of Physiology, vol. 272, no. 3, pp. F380–F388, 1997. View at Google Scholar
7. H. Sadlish, F. M. R. Williams, and W. F. Flintoff, “Functional role of arginine 373 in substrate translocation by the reduced folate carrier,” Journal of Biological Chemistry, vol. 277, no. 44, pp. 42105–42112, 2002. View at Publisher · View at Google Scholar
8. R. G. Dumitrescu and P. G. Shields, “The etiology of alcohol-induced breast cancer,” Alcohol, vol. 35, no. 3, pp. 213–225, 2005. View at Publisher · View at Google Scholar
9. K. E. McMartin, T. D. Collins, C. Q. Shiao, L. Vidrine, and H. M. Redetzki, “Study of dose-dependence and urinary folate excretion produced by ethanol in humans and rats,” Alcoholism: Clinical and Experimental Research, vol. 10, no. 4, pp. 419–424, 1986. View at Google Scholar
10. K. E. McMartin and T. D. Collins, “Role of ethanol metabolism in the alcohol-induced increase in urinary folate excretion in rats,” Biochemical Pharmacology, vol. 32, no. 17, pp. 2549–2555, 1983. View at Publisher · View at Google Scholar
11. R. T. Muldoon and K. E. McMartin, “Ethanol acutely impairs the renal conservation of 5- methyltetrahydrofolate in the isolated perfused rat kidney,” Alcoholism: Clinical and Experimental Research, vol. 18, no. 2, pp. 333–339, 1994. View at Google Scholar
12. G. R. Gapski, J. M. Whiteley, J. I. Rader et al., “Synthesis of a fluorescent derivative of amethopterin,” Journal of Medicinal Chemistry, vol. 18, no. 5, pp. 526–528, 1975. View at Google Scholar
13. J. R. Teerlink, “Overview of randomized clinical trials in acute heart failure syndromes,” American Journal of Cardiology, vol. 96, no. 6, pp. 59G–67G, 2005. View at Publisher · View at Google Scholar
14. R. M. Kedzierski and M. Yanagisawa, “Endothelin system: the double-edged sword in health and disease,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 851–876, 2001. View at Publisher · View at Google Scholar
15. D. S. Miller, “Xenobiotic export pumps, endothelin signaling, and tubular nephrotoxicants: a case of molecular hijacking,” Journal of Biochemical and Molecular Toxicology, vol. 16, no. 3, pp. 121–127, 2002. View at Publisher · View at Google Scholar
16. J. G. Blackburn, D. J. Hazen-Martin, C. J. Detrisac, and D. A. Sens, “Electrophysiology and ultrastructure of cultured human proximal tubule cells,” Kidney International, vol. 33, no. 2, pp. 508–516, 1988. View at Google Scholar
17. Y. G. Assaraf, L. C. Seamer, and R. T. Schimke, “Characterization by flow cytometry of fluorescein-methotrexate transport in Chinese hamster ovary cells,” Cytometry, vol. 10, no. 1, pp. 50–55, 1989. View at Google Scholar
18. D. S. Miller, “Protein kinase C regulation of organic anion transport in renal proximal tubule,” American Journal of Physiology, vol. 274, no. 1 43-1, pp. F156–F164, 1998. View at Google Scholar
19. R. Masereeuw, F. G. M. Russel, and D. S. Miller, “Multiple pathways of organic anion secretion in renal proximal tubule revealed by confocal microscopy,” American Journal of Physiology, vol. 271, no. 6, pp. F1173–F1182, 1996. View at Google Scholar
20. J. Jolivet, M.-P. Faure, S. C. Wong, J. W. Taub, and L. H. Matherly, “Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells,” British Journal of Cancer, vol. 76, no. 6, pp. 734–738, 1997. View at Google Scholar
21. T. Li, T. Tomimatsu, K. Ito, and T. Horie, “Fluorescein-methotrexate transport in brush border membrane vesicles from rat small intestine,” Life Sciences, vol. 73, no. 20, pp. 2631–2639, 2003. View at Publisher · View at Google Scholar
22. R. Zhao, Y. Wang, F. Gao, and I. D. Goldman, “Residues 45 and 404 in the murine reduced folate carrier may interact to alter carrier binding and mobility,” Biochimica et Biophysica Acta, vol. 1613, no. 1-2, pp. 49–56, 2003. View at Publisher · View at Google Scholar
23. J. A. Villanueva, A. M. Devlin, and C. H. Halsted, “Reduced folate carrier: tissue distribution and effects of chronic ethanol intake in the micropig,” Alcoholism: Clinical and Experimental Research, vol. 25, no. 3, pp. 415–420, 2001. View at Google Scholar
24. N. Rachdaoui, B. M. Sebastian, and L. E. Nagy, “Chronic ethanol feeding impairs endothelin-1-stimulated glucose uptake via decreased G$\alpha$11 expression in rat adipocytes,” American Journal of Physiology, vol. 285, no. 2, pp. E303–E310, 2003. View at Google Scholar
25. A. Gottsater, J. Forsblad, I. Mattiasson, and F. Lindgrde, “Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia,” International Angiology, vol. 21, no. 2, pp. 158–164, 2002. View at Google Scholar
26. I. Bruzzi, G. Remuzzi, and A. Benigni, “Endothelin: a mediator of renal disease progression,” Journal of Nephrology, vol. 10, no. 4, pp. 179–183, 1997. View at Google Scholar
27. B. Hocher, C. Thone-Reineke, C. Bauer, M. Raschack, and H. H. Neumayer, “The paracrine endothelin system: pathophysiology and implications in clinical medicine,” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 35, no. 3, pp. 175–189, 1997. View at Google Scholar
28. C. Haug, C. Grill, A. Schmid-Kotsas, A. Gruenert, and P. M. Jehle, “Endothelin release by rabbit proximal tubule cells: modulatory effects of cyclosporine A, tacrolimus, HGF and EGF,” Kidney International, vol. 54, no. 5, pp. 1626–1636, 1998. View at Publisher · View at Google Scholar
29. R. M. Kedzierski and M. Yanagisawa, “Endothelin system: the double-edged sword in health and disease,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 851–876, 2001. View at Publisher · View at Google Scholar
30. L. Dang, P. J. Seale, and X. Qu, “Effects of hypocrellin A on expression of vascular endothelial growth factor and endothelin-1 in human umbilical endothelial cells,” American Journal of Chinese Medicine, vol. 35, no. 4, pp. 713–723, 2007. View at Publisher · View at Google Scholar
31. A. Hamid and J. Kaur, “Role of signaling pathways in the regulation of folate transport in ethanol-fed rats,” Journal of Nutritional Biochemistry, vol. 20, no. 4, pp. 291–297, 2009. View at Publisher · View at Google Scholar